Myopia progression control

Myopia progression and control among school children in Hawassa town, sidama region, Ethiopia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202505621383018

Enrollment

200

Registered

2025-05-12

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

atropine 0.05 eye drop

arteficial tear

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All selected children with myopia more than -0.50Ds with less than -2.00Dc astigmatism.

Exclusion criteria

Exclusion criteria: All children with any systemic conditions like any infectious disease, DM, or cardiac abnormality All children with congenital central nervous system abnormalities like Down syndrome, cerebral palsy, and autism All children with an allergic reaction on ocular medications or atropine eye drops.

Design outcomes

Primary

Measure	Time frame
mean spherical equivalent myopia progression	—

Secondary

Measure	Time frame
side effects	—

Countries

Ethiopia

Contacts

Public ContactEndrias Marcos

associate proffesor

endromark@gmail.com+251913228108

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026